KUALA LUMPUR, May 16 (Bernama) -- Cougar Aircraft Corp has acquired the assets of the GA-7 Cougar light twin prop executive aircraft, designed and formerly produced by Grumman Gulfstream Aviation renown for military and corporate jets.
Cougar currently owns the FAA Type Certificate, production fixtures and technology needed to build this aircraft, aiming for the training market and as a platform for the next generation of personal airborne mobility.
According to a statement, the GA-7 offers an exceptionally long service life of its main wing spar at 42,000 hours, compared to a typical 12,000-hours, which means more profitable in-flight hours and less frequent aircraft fleet replacements.
With multiple markets, including training and light aviation along with transportation innovation, the GA-7 is able to generate substantial profits in both short and extended term, as the Cougar is a well-established aircraft offering a reliable and profitable training platform.
Cougar Aircraft Corp is expanding its partner network and actively seeks new business growth opportunities and additional investment to expand production.
-- BERNAMA
Thursday, 16 May 2019
Q3 MEDICAL DEVICES LIMITED ENTERS INTO A DISTRIBUTION AGREEMENT WITH MEDTRONIC FOR ITS BIODEGRADABLE BILIARY AND PANCREATIC STENT
DUBLIN, May 15 (Bernama-BUSINESS WIRE) -- Q3 Medical Devices Limited (“Q3 Medical”) based in Dublin, Ireland, announced today that it has entered into a distribution agreement with Medtronic plc for ARCHIMEDES, the first to market fully biodegradable biliary and pancreatic stent designed as an alternative to traditional plastic stents.
Medtronic’s Gastrointestinal and Hepatology business, which is part of the Minimally Invasive Therapies Group and Q3 Medical agreed to a six-year, exclusive agreement to distribute ARCHIMEDES biodegradable stent in western EU, US, and Japan; with rights to other regions. Q3 Medical will continue to expand its presence in South East Asia, Latin America, Eastern Europe, and the Middle East.
Typically, biliary and pancreatic duct stents are made of plastic or metal, however the ARCHIMEDES stent is made of a combination of dissolving materials permitting different rates of degradation depending on the patient need. Use of degrading materials in a stent, decreases reinterventions that are common with current stents and allows the potential for eliminating a stent removal procedure which is almost always done for plastic and metal stents currently. ARCHIMEDES has CE Mark.
Eric Mangiardi, President & CEO of Q3 Medical stated, “We are excited and fortunate to have partnered with a world leading medical device organization like Medtronic. Entering into this agreement is a major step toward our goal of becoming the world leading developer of biodegradable implants. Mangiardi further stated; “The promise of ARCHIMEDES is based in its potential to eliminate the second removal procedure required for traditional plastic stents, which could reduce billions of expenses from the global healthcare system while improving patient care.”
About Q3 Medical Devices
Q3 Medical Devices Limited is an Irish based holding company focused on the acquisition of novel medical device businesses with annual revenues up to EUR 10 Million. The holding company, through its expanding operations in Winsen, Germany (QualiMed Innovative Medizinprodukte GmbH, AMG International GmbH); Shanghai, China (Q-San); and Charlotte, N.C. (QualiMed-USA) is focused on the development, manufacturing, and distribution of minimally invasive devices for the treatment of patients with cardiology, peripheral vascular, and non-vascular diseases.
The wholly owned companies are focused on the continued global development and commercialization of their Core, Micro Invasive, Biodegradable, & Drug Delivery Technologies. The Company’s products are now sold in over 50 countries worldwide through its OEM, Private Label, and Own Brand Networks. Q3 Medical, through its wholly owned subsidiaries is focused on three key Verticals in which it will compete; Biodegradable Implants, Micro Invasive Technologies, and Drug Delivery Platforms.
Q3 Medical Devices Limited was formed by a global group of entrepreneurs, manufactures, distributors, industry doctors, and investors focused on the development and acquisition of medical device businesses. The company is focused on Creating Value By Helping People.
http://mrem.bernama.com/viewsm.php?idm=34554
Medtronic’s Gastrointestinal and Hepatology business, which is part of the Minimally Invasive Therapies Group and Q3 Medical agreed to a six-year, exclusive agreement to distribute ARCHIMEDES biodegradable stent in western EU, US, and Japan; with rights to other regions. Q3 Medical will continue to expand its presence in South East Asia, Latin America, Eastern Europe, and the Middle East.
Typically, biliary and pancreatic duct stents are made of plastic or metal, however the ARCHIMEDES stent is made of a combination of dissolving materials permitting different rates of degradation depending on the patient need. Use of degrading materials in a stent, decreases reinterventions that are common with current stents and allows the potential for eliminating a stent removal procedure which is almost always done for plastic and metal stents currently. ARCHIMEDES has CE Mark.
Eric Mangiardi, President & CEO of Q3 Medical stated, “We are excited and fortunate to have partnered with a world leading medical device organization like Medtronic. Entering into this agreement is a major step toward our goal of becoming the world leading developer of biodegradable implants. Mangiardi further stated; “The promise of ARCHIMEDES is based in its potential to eliminate the second removal procedure required for traditional plastic stents, which could reduce billions of expenses from the global healthcare system while improving patient care.”
About Q3 Medical Devices
Q3 Medical Devices Limited is an Irish based holding company focused on the acquisition of novel medical device businesses with annual revenues up to EUR 10 Million. The holding company, through its expanding operations in Winsen, Germany (QualiMed Innovative Medizinprodukte GmbH, AMG International GmbH); Shanghai, China (Q-San); and Charlotte, N.C. (QualiMed-USA) is focused on the development, manufacturing, and distribution of minimally invasive devices for the treatment of patients with cardiology, peripheral vascular, and non-vascular diseases.
The wholly owned companies are focused on the continued global development and commercialization of their Core, Micro Invasive, Biodegradable, & Drug Delivery Technologies. The Company’s products are now sold in over 50 countries worldwide through its OEM, Private Label, and Own Brand Networks. Q3 Medical, through its wholly owned subsidiaries is focused on three key Verticals in which it will compete; Biodegradable Implants, Micro Invasive Technologies, and Drug Delivery Platforms.
Q3 Medical Devices Limited was formed by a global group of entrepreneurs, manufactures, distributors, industry doctors, and investors focused on the development and acquisition of medical device businesses. The company is focused on Creating Value By Helping People.
http://mrem.bernama.com/viewsm.php?idm=34554
Ascom Myco 3 smartphone approved on Target Platform for Epic Rover
KUALA LUMPUR, May 15 (Bernama) -- Ascom, the healthcare ICT and mobile workflow solutions provider, announced that Ascom Myco 3 smartphone has been listed on the Target Platform for the Epic Rover healthcare application.
The app gives clinical users of Epic’s Electronic Health Record access to tools for clinical review, medication administration, specimen collection and other clinical documentation workflows right from mobile devices.
Ascom chief sales and marketing officer, Francis Schmeer said the listing was “yet another exciting step forward for the Ascom Myco 3 smartphone”.
“It is a clear illustration of how the smartphone benefits busy clinicians, enabling smooth access to key data and the ability to communicate and coordinate with colleagues, systems and patients.”
The device works with apps such as Rover to connect clinicians to patient data, colleagues and IT systems - helping to streamline workflows, boost productivity and ultimately, contribute to enhanced patient satisfaction and outcomes.
Part of the Ascom Healthcare Platform, the Ascom Myco 3 smartphone is available in cellular and Wi-Fi versions.
Running on the Android 8.1 OS, the device features HD 5” touchscreen, an integrated enterprise-grade barcode scanner, NFC functionality and a true hot-swappable battery.
It works together with Ascom and third-party software and apps to put context-rich information from multiple sources into the hands of highly mobile clinicians.
-- BERNAMA
The app gives clinical users of Epic’s Electronic Health Record access to tools for clinical review, medication administration, specimen collection and other clinical documentation workflows right from mobile devices.
Ascom chief sales and marketing officer, Francis Schmeer said the listing was “yet another exciting step forward for the Ascom Myco 3 smartphone”.
“It is a clear illustration of how the smartphone benefits busy clinicians, enabling smooth access to key data and the ability to communicate and coordinate with colleagues, systems and patients.”
The device works with apps such as Rover to connect clinicians to patient data, colleagues and IT systems - helping to streamline workflows, boost productivity and ultimately, contribute to enhanced patient satisfaction and outcomes.
Part of the Ascom Healthcare Platform, the Ascom Myco 3 smartphone is available in cellular and Wi-Fi versions.
Running on the Android 8.1 OS, the device features HD 5” touchscreen, an integrated enterprise-grade barcode scanner, NFC functionality and a true hot-swappable battery.
It works together with Ascom and third-party software and apps to put context-rich information from multiple sources into the hands of highly mobile clinicians.
-- BERNAMA
Wednesday, 15 May 2019
Hangzhou gastronomical delights target ´important window´ at Asian Cuisine Festival
KUALA LUMPUR, May 15 (Bernama) -- The Asian Cuisine Festival is expected to present Hangzhou's bid to become an important window for socialism with Chinese characteristics for a new era and build a unique global city.
The ‘Taste of Hangzhou’ will leverage the city’s profound historical culture and digital economic development strengths to showcase its allures and promote exchanges between cuisines of Hangzhou and Chinese and the Asian food culture.
During the festival, Hangzhou will also launch culinary culture tours for global tourists.
Senior official with the city's Culture, Radio, Television and Tourism Bureau, Zhang Ansheng said Hangzhou would design and roll out tours to explore the city's food, places of interest and tea.
In addition to culture, Hangzhou will also present its innovative spirit and social development achievements to the Asian peoples.
Hangzhou ‘urban brain’ which highlights current digital economy development will use its intelligent services such as consultation, reservation and evaluation to open digital food lines along the Hangzhou-Huangshan high-speed railway during the festival.
Users can customise the line, according to their own preferences and all the itineraries can be generated with bookings by just a single click.
Resembling a set of Chinese-style tableware, the logo for the Asian Cuisine Festival was selected from nearly 500 works collected worldwide, featuring a combination of Chinese bowls, chopsticks, Chinese seal and West Lake.
-- BERNAMA
The ‘Taste of Hangzhou’ will leverage the city’s profound historical culture and digital economic development strengths to showcase its allures and promote exchanges between cuisines of Hangzhou and Chinese and the Asian food culture.
During the festival, Hangzhou will also launch culinary culture tours for global tourists.
Senior official with the city's Culture, Radio, Television and Tourism Bureau, Zhang Ansheng said Hangzhou would design and roll out tours to explore the city's food, places of interest and tea.
In addition to culture, Hangzhou will also present its innovative spirit and social development achievements to the Asian peoples.
Hangzhou ‘urban brain’ which highlights current digital economy development will use its intelligent services such as consultation, reservation and evaluation to open digital food lines along the Hangzhou-Huangshan high-speed railway during the festival.
Users can customise the line, according to their own preferences and all the itineraries can be generated with bookings by just a single click.
Resembling a set of Chinese-style tableware, the logo for the Asian Cuisine Festival was selected from nearly 500 works collected worldwide, featuring a combination of Chinese bowls, chopsticks, Chinese seal and West Lake.
-- BERNAMA
Subscribe to:
Posts (Atom)